Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q1)Jun 30, 2025 | (FY)Mar 31, 2025 | (Q1)Jun 30, 2024 | (FY)Mar 31, 2024 | (Q4)Mar 31, 2024 | (Q3)Dec 31, 2023 | (Q2)Sep 30, 2023 | (Q1)Jun 30, 2023 | (FY)Mar 31, 2023 | (Q4)Mar 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | -1.66%397.56B | 2.37%1.72T | 4.27%404.27B | 2.41%1.68T | 8.76%462.44B | 1.01%415.53B | 0.32%412.54B | -0.85%387.73B | 5.90%1.64T | -3.01%425.21B |
| Cost of revenue | -2.96%302.26B | 1.09%1.3T | 2.44%311.49B | 1.11%1.29T | 6.61%347.01B | 0.37%319.72B | -1.19%320.06B | -1.52%304.06B | 5.27%1.28T | -4.08%325.5B |
| Gross profit | 2.72%95.3B | 6.62%413.04B | 10.88%92.78B | 6.97%387.41B | 15.77%115.43B | 3.20%95.81B | 5.92%92.49B | 1.67%83.67B | 8.18%362.16B | 0.63%99.71B |
| Operating expense | 0.48%81.76B | 5.08%328.95B | 10.42%81.37B | 9.64%313.05B | 10.91%80.81B | 13.63%81.45B | 6.35%77.11B | 7.61%73.69B | 9.29%285.52B | 4.12%72.86B |
| Staff costs | 3.62%35.14B | 8.59%138.54B | 12.66%33.91B | 8.75%127.58B | 11.12%32.44B | 11.17%32.61B | 7.58%32.43B | 5.11%30.1B | 5.54%117.31B | -0.60%29.19B |
| Selling and administrative expenses | 4.93%8.71B | 6.67%35.1B | 7.52%8.3B | -0.56%32.91B | 2.99%8.73B | -0.27%8.77B | -2.14%7.69B | -3.09%7.72B | 3.46%33.09B | 1.15%8.47B |
| -General and administrative expense | 4.93%8.71B | 6.67%35.1B | 7.52%8.3B | -0.56%32.91B | 2.99%8.73B | -0.27%8.77B | -2.14%7.69B | -3.09%7.72B | 3.46%33.09B | 1.15%8.47B |
| Research and development costs | -2.83%4.54B | -5.43%20.53B | -9.69%4.67B | 5.70%21.71B | 2.76%6.06B | 11.37%5.24B | 0.71%5.23B | 9.19%5.17B | 7.63%20.54B | 5.66%5.9B |
| Other operating expenses | -3.24%33.37B | 3.00%134.79B | 12.34%34.49B | 14.21%130.87B | 14.64%33.59B | 20.74%34.83B | 8.36%31.75B | 13.13%30.7B | 15.70%114.58B | 9.94%29.3B |
| Operating profit | 18.71%13.55B | 13.10%84.09B | 14.29%11.41B | -2.99%74.35B | 28.96%34.62B | -32.11%14.37B | 3.84%15.38B | -27.76%9.98B | 4.26%76.64B | -7.75%26.85B |
| Net non-operating interest income (expenses) | -151.35%-324M | 375.73%2.16B | 206.23%631M | 76.32%-783M | 139.53%338M | 84.25%-131M | 54.85%-396M | 19.95%-594M | 7.11%-3.31B | 21.70%-855M |
| Non-operating interest income | -25.37%1.26B | 69.52%7.54B | 189.86%1.69B | 344.94%4.45B | 447.94%1.73B | 360.44%1.26B | 274.47%880M | 230.68%582M | 133.41%999M | 178.76%315M |
| Non-operating interest expense | 49.91%1.58B | 2.83%5.38B | -10.20%1.06B | 21.44%5.23B | 18.63%1.39B | 25.61%1.39B | 14.75%1.28B | 28.10%1.18B | 7.98%4.31B | -2.90%1.17B |
| Net investment income | 19.38%5.97B | -40.96%7.4B | -29.07%5B | 15.68%12.53B | 393.44%3.13B | -92.36%149M | 0.59%2.21B | -9.16%7.05B | 15.40%10.84B | -152.36%-1.07B |
| Gain(Loss) on financial instruments designated as cash flow hedges | 3.72B | |||||||||
| Gain(Loss) on derecognition of available-for-sale financial assets | -44.18%3.03B | 138.97%170.6B | 1,497.68%5.42B | 36.13%71.39B | 610.21%27.41B | 1,994.75%43.86B | -98.89%508M | -150.79%-388M | -51.19%52.44B | 157.10%3.86B |
| Income from associates and other participating interests | 5.81%546M | -17.80%2.07B | -3.37%516M | 6.68%2.52B | 20.41%1.3B | 139.03%185M | 7,028.57%499M | -69.45%534M | 45.48%2.36B | 1,270.89%1.08B |
| Special income (charges) | 35.54%-379M | -165.96%-75.05B | -9.70%-588M | -17.29%-28.22B | -2.30%-24.89B | -61.52%167M | -3,257.95%-2.96B | -665.71%-536M | -846.79%-24.06B | -724.60%-24.33B |
| Less:Restructuring and mergern&acquisition | -83.58%22M | 226.70%560M | 59.52%134M | -327.84%-442M | -1,250.70%-817M | 207.07%304M | -360.00%-13M | 342.11%84M | 106.57%194M | 102.52%71M |
| Less:Other special charges | 107.56%357M | 41.28%7.37B | -61.95%172M | 19,957.69%5.22B | 1,050.10%5.85B | -13.86%-649M | -1,327.78%-442M | 786.27%452M | 124.30%26M | -34.99%509M |
| Less:Write off | --0 | 186.29%67.12B | --282M | -1.65%23.44B | -16.41%19.86B | 381.08%178M | ---- | ---- | 325.60%23.84B | 376.99%23.75B |
| Other non-operating income (expenses) | -32.76%-1.01B | -16.54%-7.14B | 9.85%-760M | -14.32%-6.12B | -6.63%-3.09B | 30.43%-942M | -59.64%-1.25B | -160.99%-843M | -8.71%-5.36B | -61.48%-2.9B |
| Income before tax | -18.40%17.65B | 46.52%184.13B | 42.25%21.63B | 14.71%125.67B | 1,374.36%38.82B | 150.87%57.66B | -77.06%13.99B | -33.76%15.2B | -39.45%109.56B | -90.20%2.63B |
| Income tax | -57.02%3.92B | 123.71%84.64B | 176.62%9.12B | 12.77%37.83B | 659.40%14.25B | 135.24%14.89B | -70.08%5.39B | -55.01%3.3B | -35.21%33.55B | -74.57%1.88B |
| Net income | 9.77%13.73B | 13.27%99.5B | 5.03%12.51B | 15.56%87.84B | 3,149.34%24.57B | 156.81%42.77B | -79.99%8.6B | -23.79%11.91B | -41.15%76.01B | -96.12%756M |
| Net income continuous operations | 9.77%13.73B | 13.27%99.5B | 5.03%12.51B | 15.57%87.84B | 3,149.47%24.57B | 156.81%42.77B | -79.99%8.6B | -23.79%11.91B | -41.15%76.01B | -96.12%756M |
| Noncontrolling interests | 72.90%4.36B | -25.60%10.15B | 11.80%2.52B | -9.92%13.64B | 61.99%8.13B | -35.48%3.07B | -94.90%190M | 37.27%2.25B | 153.45%15.14B | 81.84%5.02B |
| Net income attributable to the company | -6.15%9.37B | 20.42%89.35B | 3.45%9.98B | 21.90%74.2B | 485.75%16.44B | 233.70%39.7B | -78.57%8.41B | -30.97%9.65B | -50.59%60.87B | -125.46%-4.26B |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income attributable to common stockholders | -6.15%9.37B | 20.42%89.35B | 3.45%9.98B | 21.90%74.2B | 485.75%16.44B | 233.70%39.7B | -78.57%8.41B | -30.97%9.65B | -50.59%60.87B | -125.46%-4.26B |
| Gross dividend payment | ||||||||||
| Basic earnings per share | 1.47%32.41 | 28.15%295.98 | 7.94%31.94 | 24.80%230.96 | 519.26%52.24 | 234.87%123.1 | -78.08%26.03 | -29.61%29.59 | -49.33%185.07 | -124.81%-12.46 |
| Diluted earnings per share | 1.47%32.41 | 28.15%295.98 | 7.94%31.94 | 24.80%230.96 | 500.17%52.24 | 239.71%123.1 | -78.08%26.0241 | -29.61%29.59 | -49.33%185.07 | -126.06%-13.0546 |
| Dividend per share | 0 | 16.67%56 | 0 | 4.35%48 | 0.00%24 | 0 | 9.09%24 | 0 | 4.55%46 | 0.00%24 |
| Currency Unit | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |